Who invested in Candid Therapeutics

2 rounds we have observed, with the 6 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Raised 8 months ago

Funding summaryUpdated 26 Oct 2026

$875Mraised across 2 rounds since 2026, from 2 sources

Latest round: Venture, $505MMar 2026
Investors: 6

See who backed them

The rounds

Mar 2026
Venture$505M
Source recorded
Date not reported
Round$370M
No investor was named in the report.
Reported by Firms' own news pages

Everyone who backed them

Qiming Venture PartnersVC firm1round

RA Capital ManagementPrivate equity1round

Franklin TempletonPrivate equity1round

Cormorant Asset ManagementPrivate equity1round

Vivo CapitalPrivate equity1round

Samsara BioCapitalVC firm1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about Candid Therapeutics

Who invested in Candid Therapeutics?

Candid Therapeutics's investors include Qiming Venture Partners, RA Capital Management, Franklin Templeton, Cormorant Asset Management and Vivo Capital, and 1 more on record.

How much has Candid Therapeutics raised?

Candid Therapeutics has raised $875M across 2 rounds since 2026.

When did Candid Therapeutics last raise?

Candid Therapeutics's most recent round was a Venture of $505M in Mar 2026.

What was Candid Therapeutics's biggest round?

Its most recent round, $505M in Mar 2026, is also its largest on record.

Who backed Candid Therapeutics first?

Candid Therapeutics's first round on record, in Mar 2026, was backed by Qiming Venture Partners, RA Capital Management and Franklin Templeton and 3 others.